These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 25579345)
1. Opportunities and challenges for the nasal administration of nanoemulsions. Comfort C; Garrastazu G; Pozzoli M; Sonvico F Curr Top Med Chem; 2015; 15(4):356-68. PubMed ID: 25579345 [TBL] [Abstract][Full Text] [Related]
3. Nanoemulsions for "Nose-to-Brain" Drug Delivery. Bonferoni MC; Rossi S; Sandri G; Ferrari F; Gavini E; Rassu G; Giunchedi P Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30781585 [TBL] [Abstract][Full Text] [Related]
4. Novel O/W nanoemulsions for nasal administration: Structural hints in the selection of performing vehicles with enhanced mucopenetration. Di Cola E; Cantu' L; Brocca P; Rondelli V; Fadda GC; Canelli E; Martelli P; Clementino A; Sonvico F; Bettini R; Del Favero E Colloids Surf B Biointerfaces; 2019 Nov; 183():110439. PubMed ID: 31473410 [TBL] [Abstract][Full Text] [Related]
5. Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting. Kumar M; Misra A; Mishra AK; Mishra P; Pathak K J Drug Target; 2008 Dec; 16(10):806-14. PubMed ID: 18988064 [TBL] [Abstract][Full Text] [Related]
6. Improving Drug Delivery for Alzheimer's Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels. Cunha S; Forbes B; Sousa Lobo JM; Silva AC Int J Nanomedicine; 2021; 16():4373-4390. PubMed ID: 34234432 [TBL] [Abstract][Full Text] [Related]
7. Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs. Kotta S; Khan AW; Pramod K; Ansari SH; Sharma RK; Ali J Expert Opin Drug Deliv; 2012 May; 9(5):585-98. PubMed ID: 22512597 [TBL] [Abstract][Full Text] [Related]
8. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs. Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289 [TBL] [Abstract][Full Text] [Related]
9. Potential of nanoparticulate drug delivery systems by intranasal administration. Ali J; Ali M; Baboota S; Sahani JK; Ramassamy C; Dao L; Bhavna Curr Pharm Des; 2010 May; 16(14):1644-53. PubMed ID: 20210751 [TBL] [Abstract][Full Text] [Related]
10. Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids. Grassin-Delyle S; Buenestado A; Naline E; Faisy C; Blouquit-Laye S; Couderc LJ; Le Guen M; Fischler M; Devillier P Pharmacol Ther; 2012 Jun; 134(3):366-79. PubMed ID: 22465159 [TBL] [Abstract][Full Text] [Related]
11. In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates. Giuliani A; Balducci AG; Zironi E; Colombo G; Bortolotti F; Lorenzini L; Galligioni V; Pagliuca G; Scagliarini A; Calzà L; Sonvico F Drug Deliv; 2018 Nov; 25(1):376-387. PubMed ID: 29382237 [TBL] [Abstract][Full Text] [Related]
12. Emulsion formulations of testosterone for nasal administration. Ko KT; Needham TE; Zia H J Microencapsul; 1998; 15(2):197-205. PubMed ID: 9532525 [TBL] [Abstract][Full Text] [Related]
13. Nasal route for vaccine and drug delivery: Features and current opportunities. Lobaina Mato Y Int J Pharm; 2019 Dec; 572():118813. PubMed ID: 31678521 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and Pharmacodynamic Features of Nanoemulsion Following Oral, Intravenous, Topical and Nasal Route. Choudhury H; Gorain B; Chatterjee B; Mandal UK; Sengupta P; Tekade RK Curr Pharm Des; 2017; 23(17):2504-2531. PubMed ID: 27908273 [TBL] [Abstract][Full Text] [Related]
15. Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration. Shah B; Khunt D; Misra M; Padh H Eur J Pharm Sci; 2016 Aug; 91():196-207. PubMed ID: 27174656 [TBL] [Abstract][Full Text] [Related]
16. Lipid materials for topical and transdermal delivery of nanoemulsions. Pawar KR; Babu RJ Crit Rev Ther Drug Carrier Syst; 2014; 31(5):429-58. PubMed ID: 25271559 [TBL] [Abstract][Full Text] [Related]
17. Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies. Pires PC; Santos AO J Control Release; 2018 Jan; 270():89-100. PubMed ID: 29199063 [TBL] [Abstract][Full Text] [Related]